AVI BIOPHARMA Aktie

0,58 EUR 7,8505%

Zu Ihrem Onlinebroker

kaufen verkaufen

AVI BIOPHARMA Aktienkurs : 24.05. ( 15 Min. verzögert)
0,577 € Letzter Kurs	7,85% Veränderung	0,535 € Vortag	0,592 € Eröffnungskurs

mehr Informationen

Hoch/Tief		Volumen		Geldkurs	Briefkurs
0,592 - 0,577 Tag	1,21 - 0,440 52 Wochen	0 Tag	111 Ø 52 Wochen	0,0000000 0 Stücke	0,0000000 0 Stücke

AVI BIOPHARMA Aktienkurs

Wollen Sie wissen, wie es mit dieser Aktie weitergeht?
Wir informieren Sie kostenlos.

Erhalten Sie außerdem Expertenanalysen von:
Gevestor Täglich und John Gossens Daily DAX

18.05.

Fenwick Snags AVI BioPharma GC For Life Sciences Practice

By Keith Goldberg Law360, New York (May 18, 2012, 5:26 PM ET) -- Fenwick & West LLP has signed on AVI BioPharma Inc.'s former general counsel as a partner in the firm's life sciences practice group in Seattle. Effie Toshav, who officially...
14.05.

Effie Toshav Joins Fenwick - Broadens Life Sciences Service Platform

Formerly senior vice president, general counsel and secretary at AVI BioPharma, Ms. Toshav is based in Fenwick's Seattle office. "Effie's reputation throughout the life sciences industry as a trusted corporate counsel,...

11.05.

US Companies Reporting Midmorning EPS, May 11

... ASYS AMTECH SYS INC -0.33 0.77 NM -0.23 -43.5 Mar ATSG AIR TRANSPORT SE 0.10 0.11 -9.1 0.08 25.0 Mar AVII AVI BIOPHARMA -0.13 0.02 NM -0.07 -85.7 Mar BASI BIOANALYTICAL ...
11.05.

Potential Breakout Stock to Watch for 05/11/12: AVVC Issues News Release

(OTCBB: AVVC), Google, Inc. (NASDAQ: GOOG), Apple, Inc. (NASDAQ: AAPL), AVI Biopharma, Inc. (NASDAQ: AVII) Get an edge on the market with our Premium News Alerts that are FREE for a limited...
10.05.

AVI BioPharma Announces First Quarter 2012 Financial Results and Recent ...

AVI BioPharma, Inc. (NASDAQ:AVII) , a developer of RNA-based therapeutics, today reported financial results for the three months ended March 31, 2012, and provided an update of recent corporate devel…